Cell-permeable, cell-compatible, and cleavable linkers for covalent tethering of functional elements
US-2016355523-A1 · Dec 8, 2016 · US
US10168323B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10168323-B2 |
| Application number | US-201414204868-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 11, 2014 |
| Priority date | Mar 15, 2013 |
| Publication date | Jan 1, 2019 |
| Grant date | Jan 1, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides compositions and methods for capture and identification of the cellular targets of a bioactive agent. In particular, provided herein are bioactive agents tethered to capture ligand, cellular targets (optionally tagged with a reporter), capture proteins (optionally present as capture dimers), surfaces (e.g., displaying, capture ligands, capture proteins, or capture dimers), and methods of capturing and identifying the cellular targets of a bioactive agent therewith.
Opening claim text (preview).
The invention claimed is: 1. A kit comprising: (a) a cell that expresses a fusion of a bioluminescent reporter and a cellular target of a small molecule bioactive agent, wherein the cellular target is located within a cell; (b) the small molecule bioactive agent tethered by a carbamate linker to a chloroalkane capture ligand, wherein the small molecule bioactive agent tethered to a chloroalkane capture ligand is cell permeable, and wherein the small molecule bioactive agent is capable of non-covalently binding to the cellular target upon interaction thereof under intracellular conditions; and (c) a solid surface displaying a capture protein, wherein the capture protein comprises a modified dehalogenase configured to covalently bind to the chloroalkane capture ligand upon interaction thereof. 2. The kit of claim 1 , wherein the bioluminescent reporter comprises a polypeptide with at least 70% sequence identity with SEQ ID NO.: 3. 3. The kit of claim 1 , wherein the capture protein comprises at least 70% sequence identity with SEQ ID NO.: 1. 4. The kit of claim 1 , wherein the solid surface is selected from the list consisting of: a well, a tube, a slide, a plate, a matrix, resin or a bead. 5. The kit of claim 4 , wherein the solid surface is magnetic or paramagnetic.
involving human or animal cells (immunoassay G01N33/56966; immunoassays of protozoa G01N33/56905; protozoa in screening assays C12Q1/025) · CPC title
with an insoluble carrier for immobilising immunochemicals · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.